These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38733856)
1. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1. Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856 [TBL] [Abstract][Full Text] [Related]
2. [Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review]. Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Viaño J Rev Neurol; 2012 Nov; 55(9):528-32. PubMed ID: 23111991 [TBL] [Abstract][Full Text] [Related]
3. Lesions of the corpus callosum in children with neurofibromatosis 1. Mimouni-Bloch A; Kornreich L; Kaadan W; Steinberg T; Shuper A Pediatr Neurol; 2008 Jun; 38(6):406-10. PubMed ID: 18486822 [TBL] [Abstract][Full Text] [Related]
4. Neurological complications involving the central nervous system in neurofibromatosis type 1. Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129 [TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Pascual-Castroviejo I; Pascual-Pascual SI Childs Nerv Syst; 2012 Dec; 28(12):2177-80. PubMed ID: 23001021 [TBL] [Abstract][Full Text] [Related]
6. Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features. Aydin S; Kurtcan S; Alkan A; Guler S; Filiz M; Yilmaz TF; Sahin TU; Aralasmak A Clin Imaging; 2016; 40(6):1092-1095. PubMed ID: 27423006 [TBL] [Abstract][Full Text] [Related]
7. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Molloy PT; Bilaniuk LT; Vaughan SN; Needle MN; Liu GT; Zackai EH; Phillips PC Neurology; 1995 Oct; 45(10):1897-902. PubMed ID: 7477989 [TBL] [Abstract][Full Text] [Related]
8. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images. Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602 [TBL] [Abstract][Full Text] [Related]
9. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis. Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157 [TBL] [Abstract][Full Text] [Related]
10. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain? Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245 [TBL] [Abstract][Full Text] [Related]
11. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1. Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181 [TBL] [Abstract][Full Text] [Related]
12. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes. Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909 [TBL] [Abstract][Full Text] [Related]
13. Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1. Margariti PN; Blekas K; Katzioti FG; Zikou AK; Tzoufi M; Argyropoulou MI Eur Radiol; 2007 Feb; 17(2):433-8. PubMed ID: 16733674 [TBL] [Abstract][Full Text] [Related]
14. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects. Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1. Balestri P; Calistri L; Vivarelli R; Bartalini G; Mancini L; Berardi A; Fois A Childs Nerv Syst; 1993 Dec; 9(8):448-51. PubMed ID: 8124670 [TBL] [Abstract][Full Text] [Related]
16. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. DeBella K; Poskitt K; Szudek J; Friedman JM Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507 [TBL] [Abstract][Full Text] [Related]
17. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428 [TBL] [Abstract][Full Text] [Related]
18. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice. Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751 [TBL] [Abstract][Full Text] [Related]
19. The management of brainstem gliomas in patients with neurofibromatosis 1. Pollack IF; Shultz B; Mulvihill JJ Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565 [TBL] [Abstract][Full Text] [Related]
20. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]